EORTC embarked on a membership renewal programme
5 Feb 2021
In 2020, EORTC embarked on an ambitious membership renewal programme, in order to comply with GDPR regulation and to ensure that all information of its members are up to date. Following this renewal programme, EORTC can confirm over 2800 direct members coming from 730 institutions. The network comprises of members coming from 48 countries around the world, with the top ten from Europe.

EORTC is a truly multidisciplinary organisation of which 15% are organ specialists. Its membership spans over 30 different disciplines conducting clinical research.

“One of the uniqueness of EORTC is that we conduct trials across multiple tumours and the members are stratified across groups related to their tumour of interest. We are able to attract leading clinical researchers across the globe, conducting practice changing trials,” said Denis Lacombe, EORTC Director General. “As EORTC approaches its 60th anniversary next year, we remain fully committed to all cancer patients, our members, partners and supporters, ensuring the organisation stays true to its mission and paves the way to innovation in cancer care.”
Related News
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
Independent, academic cancer trials are vital to improve patient outcomes worldwide
28 Apr 2026
